Close Menu

NEW YORK – Opko's BioReference Laboratories announced Friday it will provide testing for a drive-through facility for SARS-CoV-2 sample collection in partnership with the New York State Department of Health.

The drive-through facility is in New Rochelle, New York, which has been the epicenter of the state's COVID-19 outbreak. The facility started testing Friday with residents in the city who have been quarantined already. The testing will be by appointment only, according to Governor Andrew Cuomo. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.